Mezun Olduğu Tıp Fakültesi ve Yılı
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, 1990
Uzmanlık Eğitimi Aldığı Yer ve Yılı
Haydarpaşa Numune Hastanesi, 1994-1999 (İç Hastalıkları)
Marmara Üniversitesi Tıp Fakültesi 1999-2003 (Hematoloji)
Mesleki Deneyim
Gülçimen Sağlık Ocağı, Bulanık Merkez Sağlık Ocağı (Muş) 1990-1992
İpsala Devlet Hastanesi, Acil servis, 1992-1994
Haydarpaşa Numune Hastanesi Eğitim ve Araştırma Hastanesi, İç Hastalıkları, 1994-1999
Beykoz Devlet Hastanesi, İç Hastalıkları Uzmanı, 1999-1999
Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları-Hematoloji, 1999-2003
Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları-Hematoloji, 2003-2004
Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları-Hematoloji, 2004-2011
Yabancı Araştırmacı (Fellowship) Department of Pathology, Hemostasis and Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, Chicago, Illinois, USA,2007-2009
Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları-Hematoloji, 2011-2013
Bahçeşehir Üniversitesi Tıp Fakültesi İç Hastalıkları ABD 2016- 2019 Emekli
Göztepe Medicalpark Hastanesi, Hematoloji ve Kemik İliği Nakil Ünitesi sorumlusu 2013-2022
Tıbbi İlgi Alanları
Kemik iliği Nakli
Lösemiler
Lenfomalar
Anemiler
Miyelodisplastik sendrom
Miyeloproliferatif hastalıklar
Trombosit hastalıkları
Kanama ve tromboza eğilimli hastalıklar
Özellikli İşlem
Kemik İliği Nakli
Ödüller ve Teşekkürler
Çetiner, M., Ovalı, E., Yavuz, M.N., Ratip, S., Kartı, S., Adıgüzel, C., Argon, D., Fıratlı-Tuğlular, T., Bayık, M., “Radyasyonun kemik iliği ve CD 34+ hücreler üzerine olan olumsuz etkisinin önlenmesinde amifostine’nin rolü”. XXVIII. Ulusal Hematoloji Kongresi “Deneysel Hematoloji en iyi bildiri ödülü” 2-4 Kasım 2000 İZMİR
Argon D, Yüksel M, Adıgüzel C, Sönmezoğlu M, , Yalçın S, Bayık M .”Aferez Yoluyla elde edilmiş trombosit süspansiyonlarının, lökositten arındırılmaları, Işınlanmaları ve saklama sürelerinin serbest radikal oluşumu üzerine etkileri”, XXX. Ulusal Hematoloji Kongresi, en iyi bildiri ödülü, XXX. Ulusal Hematoloji Kongresi, 10-14 Ekim 2003, İSTANBUL
A.Bilimsel Yayınlar Uluslararası hakemli dergilerde yayımlanan makaleler
A1. Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J.An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost. 2022 Jan-Dec;28
A2. Umit EG, Kara O, Adiguzel C. (Re: Schelfhout J, Bonafede M, Cappell K, et al. Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant. Curr Med Res Opin. 2020; 36(1):33-41. Schelfhout J, Brown H, House JA, Raval AD. Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant. Curr Med Res Opin. 2020;36(1):43-50.) Curr Med Res Opin. 2020 Apr;36(4):607.
A3. Yabas Kiziloglu O, Mestanoglu M, Totuk Gedar OM, Adiguzel C, Toygar O. Recurrence of acute lymphoblastic leukemia manifesting as serous retinal detachments and optic disc swelling.Int Ophthalmol. 2018 Aug;38(4):1791-1795.
A4. Kantarcıoğlu B, Türköz HK, Yılmaz G, Pepedil Tanrıkulu F, Kaygusuz Atagündüz I, Adıgüzel C, Fıratlı Tuğlular T. Aplastic anemia associated with oral terbinafine: a case report and review of the literature. Turk J Haematol. 2014 Dec 5;31(4):411-6.
A5. Toptas T, Kaygusuz-Atagunduz I, Kani HT, Adiguzel C, Firatli-Tuglular T. Levofloxacin for the treatment of severe refractory BK virus-associated hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of three cases. Oncol Lett. 2014 Oct;8(4):1775-1777.
A6. Fareed J, Adiguzel C, Thethi I.Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism. Thromb J. 2011 Mar 28;9(1):5.
A7. Walenga JM, Adiguzel C. Drug and dietary interactions of the new and emerging oral anticoagulants. Int J Clin Pract . 64(7):956-67 (2010).
A8. Kaygusuz I, Koc M, Arikan H, Adiguzel C, Cakalagaoglu F, Tuglular TF, Akoglu E. Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis. Ren Fail. 32(2):273-6 (2010).
A9. Knesek MJ, Litinas E, Adiguzel C, Hopkinson W, Hoppensteadt D, Lassen M, Fareed J. Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins. Clin Appl Thromb Hemost. 16(1):42-50 (2010).
A10. Zhu H, Hoppensteadt D, Iqbal O, Litinas E, Adiguzel C, Fareed J. Relative purity of different bovine thrombin preparations. Clin Appl Thromb Hemost. 15(6):681-8 (2009).
A11. Adiguzel C, Iqbal O, Demir M, Fareed J. European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats. Clin Appl Thromb Hemost. 15(6):645-51 (2009).
A12. Sayitoglu, M., I.C. Haznedaroğlu, O. Hatirnaz, Y. Erbilgin, S. Aksu, E. Koca, C. Adiguzel, M. Bayik, I. Akalin, Z. Gülbas, M. Akay, A. Unal, L. Kaynar, E. Ovali, M. Yilmaz, M. Yenerel, S. Dagdas, G. Ozet, C. Ar, Y. Aydin, T. Soysal, B. Durgun, O. Ozcebe, A. Tukun, O. Ilhan ve U.Ozbek. “Effects of Imatinib Mesylate on Renin-Angiotensin System (RAS) Activity During the Clinical Course of Chronic Myeloid Leukaemia” J Int Med Res, 37, 1018-1028 (2009).
A13. Adiguzel, C., O. Iqbal, D. Hoppensteadt, W. Jeske, J. Cunanan, E. Litinas, H. Zhu, J.M. Walenga ve J. Fareed. “Comparative Anticoagulant and Platelet Modulatory Effects of Enoxaparin and Sulodexide”. Clin Appl Thromb Hemost, 15(5):501-11. (2009).
A14. Kannan, M., R. Saxena, C. Adiguzel ve J. Fareed. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients. Semin Thromb Hemost , 35, 337-343 (2009).
A15. Adiguzel, C., V. Bansal, E. Litinas, J. Cunanan, O. Iqbal, K. Nelson, M. Kannan, D. Hoppensteadt ve J. Fareed. “Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin”. Clin Appl Thromb Hemost, 15, 145-151 (2009).
A16. Adiguzel, C., W.P. Jeske, D. Hoppensteadt, J.M. Walenga, V. Bansal ve Fareed J. “Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products”. Clin Appl Thromb Hemost, 15, 137-144 (2009).
A17. Adiguzel, C., S.U. Bozkurt, I. Kaygusuz, A. Uzay, Tecimer T, ve M. Bayik. “Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature”. APMIS, 117, 222-229 (2009).
A18. Heilmann, L., M. Schorch, T. Hahn, G. Adasz, K. Schilberz, C. Adiguzel ve J. Fareed. “Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study”. Semin Thromb Hemos. 34, 794-802 (2008).
A19. Zhu, H., D. Hoppensteadt, C. Adiguzel, R.L. Bick ve J. Fareed. “Comparison of immunogenic potentials of bovine thrombin preparations”. Clin Appl Thromb Hemost, 15, 41-49 (2009).
A20. Zhu, H., D. Hoppensteadt, R. Wahi, J. Cunanan, C. Adiguzel, R. Bick ve J. Fareed. “Reduced Immunogenic Potential of Membrane Filtered Bovine Thrombin Preparations for Hemostatic Application”. Clin Appl Thromb Hemost, 15, 32-40 (2009).
A21. Clark, M., D. Hoppensteadt, J. Walenga, L. Myers, J. Cunanan, W. Jeske, C. Adiguzel, O. Iqbal ve J. Fareed. “Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate”. Int Angiol, 27, 370-376 (2008).
A22. Iqbal, O., C. Adiguzel, B.E. Lewis, J. Cunanan ve J. Fareed. “Argatroban in percutaneous Coronary interventions”. Semin Thromb Hemost, 34(Suppl 1), 62-74 (2008).
A23. Adiguzel, C., O. Iqbal, J. Cunanan, W. Jeske, D. Hoppensteadt, J.M. Walenga ve J. Fareed. “Potency adjusted generic versions of argatroban can be differentiated from branded argatroban in thrombin generation and platelet activation assays”. Semin Thromb Hemost, 34(Suppl 1), 108-117 (2008).
A24. Fareed, J., J.M. Walenga, W. Jeske, D. Hoppensteadt, M. Prechel, O. Iqbal, C. Adiguzel, M. Clark, E. Litinas, J. Cunanan, R. Linhardt ve J. Harenberg. “Biological profile of the hyper/oversulfated chondroitin sulfate contaminant isolated from recall heparin”. Semin Thromb Hemost, 34(Suppl 1), 119-127 (2008).
A25. Fareed, J., W. Jeske, D. Fareed, M. Clark, R. Wahi, C. Adiguzel ve D. Hoppensteadt. “Are all low molecular weight heparins equivalent in the management of venous thromboembolism?” Clin Appl Thromb Hemost, 14, 385-392 (2008).
A26. Hoppensteadt, D.A., R. Wahi, C. Adiguzel, O. Iqbal, E. Ramacciotti, R.L. Bick, H.L. Messmore, V. Bansal ve Fareed J. “Contaminant in the recalled unfractionated heparin preparations: where is the problem?” Clin Appl Thromb Hemost, 14, 261-266 (2008).
A27. Fareed, J., O. Iqbal, J. Cunanan, M. Demir, R. Wahi, M. Clarke, C. Adiguzel ve R. Bick. “Chaining trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?” Int Angiol, 27, 176-192 (2008).
A28. Fareed, J., D.A. Hoppensteadt, D. Fareed, M. Demir, R. Wahi, M. Clarke, C. Adiguzel ve R. Bick. “Survival of heparins, oral anticoagulants, and aspirin after the year 2010”. Semin Thromb Hemost, 34, 58-73 (2008).
A29. Jeske, W.P., J.M. Walenga, D.A. Hoppensteadt, C. Vandenberg, A. Brubaker, C. Adiguzel, M. Bakhos ve J. Fareed. “Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic”. Semin Thromb Hemost, 34, 74-85 (2008).
A30. Hoppensteadt, D.A., N. Fabbrini, R.L. Bick, H.L. Messmore, C. Adiguzel, J. Fareed. “Laboratory evaluation of the antiphospholipid syndrome”. Hematol Oncol Clin North Am, 22, 19-32 (2008).
A31. Bizargity, P., C. Adıguzel, G. Ozilhan, M. Bayık ve E. Eksioglu-Demiralp. “İmatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia”. Clin Lab Haem: 27:1-2 (2005).
A32. Cetiner, M., C. Adıgüzel, D. Argon, S. Ratip, E. Ekşioğlu-Demiralp, T. Tecimer ve M. Bayık. “Hairy Cell Leukemia in Father and Son”. Med Oncol, 20, 375-378 (2003).
A33. Demirçay, Z., A. Cömert ve C. Adıgüzel. “Leg Ulsers and Hydroxyurea: Report of Three Cases with Essential Thrombocythemia”. İnternational Journal of Dermatology, 41, 872-874 (2002).
B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler
B1. Dilvin Guney, Aysin Tulunay, Funda Pepedil, Isik Kaygusuz, Cafer Adiguzel, Tülin Tuglular, Muzaffer Demir, Emel Eksioglu-Demiralp, and Fikriye Uras. Tyro3, Axl Ve Mer (TAM) Receptors On Surfaces of Mononuclear Cells in Patients with B-Cell Chronic Lymphocytic Leukemia. Blood (ASH Annual Meeting Abstracts), Nov 2012; 120: 4588.
B2. Debra Hoppensteadt, Hussein Khan, Indermohan Thethi, Muzaffer Demir, Cafer Adiguzel, Saud Rahman, and Jawed Fareed. Inflammatory and Thrombotic Mediators in Small Cell Lung Carcinoma: Potential Role in Thromboembolic Complications. Blood (ASH Annual Meeting Abstracts), Nov 2011; 118: 2294.
B3. Jawed Fareed, Cafer Adiguzel, Debra Hoppensteadt, Walter Jeske, Jeanine M. Walenga, Bruce E Lewis, Harry L. Messmore, Jr., and Vinod Bansal. Prevalence of Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011. Relevance to Heparin Contaminants. Blood (ASH Annual Meeting Abstracts), Nov 2011; 118: 4326.
B4. Microscopic Examination Of Bone Marrow Aspiration Smears: Diagnostic Agreement Of Hematologists And Hematopathologists On Common Hematological Diagnoses T Toptas, M Sungurtekin, G Gokoglu, M Gun, T Kasikci, G Yilmaz, B Kantarcioglu, I Kaygusuz, C Adiguzel, S Bozkurt, T Firatli-Tuglular, M Bayik. 16th Congress of the European Hematology Association London, 2011 (1755).
B5. Levofloxacin For Bk Virus-Associated Hemorrhagic Cystitis In The Post-Hematopoietic Stem Cell Transplantation Period T Toptas, I Kaygusuz, T Kani, B Kantarcioglu, G Yilmaz, C Adiguzel, T Firatli-Tuglular, M Bayik. 16th Congress of the European Hematology Association London, 2011 (1495).
B6. The Effect Of Complete Molecular Response On Progression-Free Survival In Patients With Chronic Myeloid Leukemia Receiving Imatinib Mesylate I Kaygusuz, T Toptas, B Kantarcioglu, G Yilmaz, C Adiguzel, E Eksioglu-Demiralp, T Firatli-Tuglular, M Bayik 16th Congress of the European Hematology Association London, 2011 (0154).
B7. Jawed Fareed, Debra Hoppensteadt, Josephine Cunanan, Walter Jeske, Cafer Adiguzel, He Zhu, Cinara Echart, and Massimo Iacobelli. Prolonged Administration of Defibrotide Is Non-Immunogenic in Rats and Dogs. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 4180.
B8. Walenga, J., M. Bakhos, D. Hoppensteadt, C. Adiguzel, J. Cunanan ve W. Jeske. “Immunogenicity Of Low Molecular Weight Heparins And Biosimilars”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-MO-399, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B9. Gray, A., D. Hoppensteadt, L. Myers, O. Iqbal, C. Adiguzel, ve J. Fareed. “Assay Dependent Variations In The USP Potency Standardized Unfractionated Heparins”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-MO-136, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B10. Adiguzel, C., E. Litinas, J. Cunanan, D. Hoppensteadt, J. Walenga ve J. Fareed. “Differential Thrombin Generation Inhibition By Branded And Generic Low Molecular Weight Heparins (LMWHs) As Studied By Using Fluorescence Substrate Based Kinetic Method”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-MO-139, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B11. Adiguzel, C., J. Fareed, J. Walenga, D. Hoppensteadt, W. Jeske, O. Iqbal, J. Cunanan ve E. Litinas. “Generic Versions Of Argatroban Can Be Differentiated From Branded Argatroban In The Thrombin Generation Assays (Tga)”. Journal of Thrombosis and Haemostasis. 7 (Suppl 2), PP-MO-140, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B12. Hoppensteadt, D., J. Fareed, V. Bansal, O. Iqbal, C. Adiguzel ve H. Messmore. “Activation Of Prekallikrein By Contaminated Heparins, Isolated Contaminant And Related Hypersulfated Chondroitin Sulfate Preparations: Pharmacologic Implications”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-MO-143, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B13. Bansal, V., E. Litinas, D. Hoppensteadt, C. Adiguzel ve Jawed Fareed. “Contaminants In Heparin! A Call For Substitute Anticoagulants”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-TH-145, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B14. Bansal, V., J. Cunanan, D. Hoppensteadt, C. Adiguzel, O. Iqbal ve J. Fareed. “Fibrinokinetic Deficit In Chronic Kidney Disease And End Stage Renal Disease Patients Contributes To The Hemostatic Abnormalities”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-261, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).
B15. Adiguzel, C., J. Walenga, H. Messmore, , D. Hoppensteadt, R. Wahi, ve J. Fareed, “
Bioavailability Of Over Sulfated Chondroitin Sulfate. Immunologic Implications”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-TH-390, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)
B16. Litinas, E., C. Adiguzel, W. Jeske, D. Hoppensteadt, H. Messmore, J. Walenga ve J. Fareed. “
Increased Antithrombotic And Bleeding Effects Of Contaminated Heparins; Hematological Implications”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-385, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)
B17. Walenga, J., C. Adiguzel ,J. Cunanan, D. Hoppensteadt, O. Iqbal ve M. Bakhos. “
Fibrin Clot Formation Differs In The Presence Of Branded And Generic Enoxaparins”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-387, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)
B18. Hoppensteadt, D., O. Iqbal, C. Adiguzel, J. Cunanan ve J. Fareed. “
Upregulation Of Procalcitonin In Cancer Patients With Venous Thrombosis”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-WE-482, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009)
B19. Iqbal, O., C. Adiguzel, J. Fareed, D. Hoppensteadt, E. Litinas, H. Zhu, ve A Halaris. “Selective Serotonin Reuptake Inhibitors Influence Agonist-Induced Platelet Aggregation. Preliminary Results from Comorbidity of Depression and Cardiovascular Disease Study”. Blood, 112, 4556, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).
B20. Bansal, V., J. Cunanan, C. Adiguzel, E. Litinas, K. Nelson, ve J. Fareed. A Higher “Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin”. Blood, 112, 3022, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008).
B21. Zhu, H., D. Hoppensteadt, R. L. Bick, C. Adiguzel, R. Wahi ve Jawed Fareed. “Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins”. Blood 112, 5463, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).
B22. Fareed, J., D. Hoppensteadt, W. Jeske, C. Adiguzel, O. Iqbal ve J.M. Walenga. “Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions”. Blood, 112, 4048, 2009, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).
B23. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt ve J. Fareed. “Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities”. Blood, 112, 4078, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).
B24. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt ve J. Fareed. “Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses”. Blood, 112, 4079, 2008, (50.ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008).
B25. Fareed, J., O. Iqbal, D. Hoppensteadt, C. Adiguzel, M. Iacobelli ve J.M. Walenga. “Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight Heparins”. Blood, 112: 4086, 2008;. (50. ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).
B26. Adiguzel, C., D. Hoppensteadt, J. Cunanan, R. Bick, J. Walenga ve J. Fareed “Prevalence of heparin induced thrombocytopenia antibodies in cancer patients treated with a low molecular weight heparin”. J Clin Oncol (May 20 suppl) 26, abstr 20601, 2008, (2008 ASCO Annual Meeting, Chicago, USA).
B27. Fareed, J., O. Iqbal, D. Fareed, D. Hoppensteadt, C. Adiguzel ve J. Cunanan “Upregulation of procalcitonin in cancer patients with venous thrombosis is independent of sepsis”. J Clin Oncol (May 20 suppl), 26, abstr 20583, 2008, (2008 ASCO Annual Meeting, Chicago, USA).
B28. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes, J. Fareed, J. Walenga,. “Distinct batches of branded parnaparins have differents HIT sera mediated platelet aggregation”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 93, 2008.
B29. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes ve J. Fareed. “Generic versions of LMWH can be differenciated in HIT sera mediated platelet aggregation”. XXIII World Congress of the International Union of Angiology, Athens, (Oral Presentation), 93, 2008.
B30. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan, W. Jeske, E.Ramacotti, M. Gomes, K. Nelson ve J. Fareed. “The inhibition of microparticles generation, platelet aggregation and activation by enoxaparin”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.
B31. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan, E.Ramacotti, M. Gomes, K. Nelson ve J. Fareed. “Danaparoid mediated inhibition of microparticles generation, platelet aggregation and P-selectin expression”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.
B32. Ramacotti, E., M. Gomes, C. Adiguzel, A.Comerota, D. Hoppensteadt , A. Nicolaides ve J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic Biochimico- Cutenox-CT), 40 mg o.d 6-14 days in acutely medically ill patients”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 82, 2008.
B33. Gomes, M., E.Ramacotti, C. Adiguzel, A. Comerota, D. Hoppensteadt , A. Nicolaides ve J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic Biochimico- Cutenox-CT), 40 mg o.d 10 days in healthy volunteers”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 81, 2008.
B34. Walenga, J, V. Bansal, D. Hoppensteadt, C. Adiguzel, H. Messmore, R. Bick ve Jawed Fareed. “Decrease prevalance of antiheparin platelet factor 4 antibodies in end steage renel disease”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 68, 2008.
B35. Clark M., D. Hoppensteadt , J. Cunanan, C. Adiguzel, R. Leinhardt ve J. Fareed. “Molecular profiling of a heparinase resistant glycosaminoglycan in contaminated heparins. Comparative studies with noncontaminated heparin and O-sulfonated chodroitin sulfate”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 65,2008.
B36. Zhu, H., D. Hoppensteadt , J. Cunanan, C. Adiguzel, L. Bick ve J. Fareed. “Reduced immunogenic potential of membrane filtered bovine thrombine preparations for hemostatic application”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 27, 2008.
B37. Clark, M., D. Hoppensteadt , J. Cunanan, C. Adiguzel, R. Leinhardt ve J. Fareed. “Comparative anticoagulant and antiprotease actions of O-sulfated chondroitin sulfate (OSCS), unfractionated heparin (UFH), and their mixtures”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 25, 2008.
B38. Walenga, J., W. Jeske, D. Hoppensteadt, O. Iqbal, C. Adiguzel, H. Messmore ve J. Fareed. “Differential heparin-induced thrombocytopenic potential of low molecular weight heparins”. XXIII World Congress of the International Union of Angiology (Oral Presentation), 25 , 2008.
B39. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “Suledoxide mediated inhibition of tissue factor activation of platelet a potential mechanism for the observed therapeutic effects in diabetic nephropathy”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#4281, 2008.
B40. Adiguzel, C., O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “Comparative anticoagulant effects of suledoxide and enoxaparin in citrated whole blood”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#2388, 2008.
B41. Samiccannu, M.R., C. Adiguzel , O. Iqbal, D. Hoppensteadt , J. Cunanan ve J. Fareed. “The inhibition of microparticle generation by anticoagulant drugs”. Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#7073, 2008.
B42. Hoppensteadt, D., V. Bansal, J. Cunanan, K. Patel, C. Adiguzel, R. Wahi ve J. Fareed. “Prevalence of non-specific cross-reactive epitopes to bovine factor VA light chain fragments in end stage renal disease, acute coronary syndrome and burn patient plasma”. Haemostaseologie (52. GTH Annual Meeting Abstracts), A 93, 2008.
B43. Adiguzel, C., O. Iqbal, M. Sammikannu, J. Cunanan, W. Jeske, D. Hoppensteadt, ve J. Fareed. “Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation Assays”. Blood, 110, 4007, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).
B44. Adiguzel, C., O. Iqbal, D. Fareed, D. Hoppensteadt, W. Jeske, M.Sammikannu ve J. Fareed. “Modulation of Platelet Function by Recombinant Thrombomodulin Hematologic Implications”. Blood; 110, 3898, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).
B45. Iqbal, O., C. Adiguzel, D. Hoppensteadt, J. Cunannan, ve J. Fareed. “Factor Xa Inhibitors Can Be Differentiated İn Xa, Iıa And Microparticle Generation And Other Whole Blood Based Assays”. Blood, 110, 931,2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).
B46. Demir, M., A. Ciftci, D. Hoppensteadt, G. Altiay, M. Tobu, O. Iqbal, D. Fareed, C. Adiguzel, M. Kujawski ve J. Fareed. “ProteinChip Array Profiling and Markers of Inflammation and Thrombin Generation in Plasma Samples from Lung Cancer Patients and Their Modulation by Chemotherapy with or without Warfarin Anticoagulation”. Blood, 110, 3978, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).
B47. Kujawski, M.R, M. Prechel, H. Zhu, J. Walenga, D. Hoppensteadt, J. Cunanan, C. Adiguzel ve J. Fareed. “A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples”. Blood, 110, 3205, 2007, (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).
B48. N. Fabbrini, D. Hoppensteadt, H. Messmore, R. Bick, C. Adiguzel ve J. Fareed. “Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome: Potential Implication in Inflammatory Responses and Thrombosis”. Blood, 110, 1740, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).
B49. Adıgüzel C, Kaygusuz I, Birtaş Ateşoglu E, Noyan F, Çetiner M, Demiralp E, Fıratli-Tuğlular T, Bayık M. Chronic Myelogenous Leukemia occurring in mother and son. 1st International Lymphoma-Leukemia-Myeloma Congress, Abstract No:139, page 116, Fethiye/Muğla, 24-27 May 2007
B50. Adıgüzel, C., S. Uyar-Bozkurt, T. Tecimer, E. Birtaş, I. Kaygusuz, F. Noyan, A. Uzay ve M. Bayık. “HHV-8 Negative Primary Effusion Lymphoma in a HIV Negative Patient” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.
B51. Uzay, A., C. Adıgüzel, M. Demir, M. Bayık. “The in vitro Effect of Different Molecular Weight Hydroxyethyl Starch Solutions and Saline on Platelet Aggregation” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.
B52. Noyan, F., E. Birtaş, C. Adıgüzel, I. Kaygusuz, M. Çetiner, , T. Fıratlı-Tuğlular ve M. Bayık, , “A VAD Therapy Resistant Multiple Myeloma Transformed From CLL” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.
B53. Birtaş, E., Z. Odabaşı, T. Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, V. Korten ve M. Bayık. “Epidemiology of Bacterial Infections in Febrile Neutropenic Patients Having Hematological Malignancies in Marmara University Hospital, İstanbul, Turkiye” XXXth World Congress of the International Society of Hematology, İstanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.
B54. Eksioglu-Demiralp,E., P. Bizargity, C. Adiguzel, G. Ozilhan ve M. Bayik. “Imatinib Does Not Inhibit Neutrophil Oxidative Burst Function in Patients with Chronic Myelogenous Leukemia (CML)”. The American Society of Hematology 46th Annual Meeting and Exposition, December 9-12, USA. , Blood (ASH Annual Meeting Abstracts, 104: Abstract 4673 ) 2004
B55. Çetiner, M., S. Kalaça, S. Ratip, Ç. Yazgan, C. Adıgüzel, S. Kalayoğlu-Beşışık, D. Argon, I. Kaygusuz, G. Aktuğlu ve M. Bayık, “Quality of Life Assessment of Haematopoietic Stem cell Transplantationpatients in İstanbul: a Pilot Study,” 30th Annual Meeting of the European Group for Blood and Marrow Transplantation, Barcelona, Bone Marrow Transplantation, Vol. XXXIII, 2004
B56. Adıgüzel, C., M. Sönmezoğlu, D. Argon, T. Akdeniz, E.Z. Demiralp ve M. Bayık. “Effects of irradiation and filtration on viability of platelets”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, pg24, 5-9 Temmuz 2003.
B57. Yüksel, M., D. Argon, C. Adıgüzel, M. Sönmezoğlu, M. Bayık ve S. Yalçın. “Effects of gamma irradiation and storage on apheresis platelets: The role of reactive oxygen species”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, 5-9 Temmuz 2003, pg 5
B58. Sönmezoğlu, M., D. Argon, C. Adıgüzel ve M. Bayık. “Evaluation of storage conditions of blood bank by measuring of free hemoglobin in red cell concentrates and whole blood”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, pg55, 5-9 Temmuz 2003.
B59. Argon, D., M. Sönmezoğlu, C. Adıgüzel ve M. Bayık. “Effects of prestorage leukocyte depletion on the platelet storage lesion”. VIII European Congress of The İnternationale Society of Blood Transfusion, İstanbul, 5-9 Temmuz 2003, pg55
B60. Kartı, S.S., S. Ratip, M. Yılmaz, S. Ukınç, A. Örem, C. Adıgüzel, F. Dane, N. Kandemir, E. Ovalı ve M. Bayık. “Therapeutic Trial of Cobalamin in Patients with Normal Serum Cobalamin Levels and Predicted Cobalamin Deficiency”. 7 th Meeting of the European Hematology Association, Florence, İtaly, The Hematology Journal suppl., Vol. 3. 2002.
C. Yazılan uluslararası kitaplar veya kitaplarda bölümler
D. Ulusal hakemli dergilerde yayımlanan makaleler:
D1. Birtaş-Ateşoğlu, E., T.Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, M. Bayık. “A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate”, Tr J Haematol, 24, 28-31 (2007)
D2.Kaygusuz, I., Z. Odabaşı, C. Adıgüzel, F. Noyan, E. Birtaş, V. Korten, T. Fıratlı-Tuğlular, M. Çetiner, M Bayık. “Complete heart block in a neutropenic patient with invasive aspergillosis”, Tr J Haematol, 23, 205-208 (2006)
D3.Çetiner, M., T. Fıratlı-Tuğlular, Y. Özen-Al Ahdab, H. Al Ahdab, M. Köse, F. Noyan, C. Adıgüzel, E. Ovalı, M. Bayık. “Amifostine treatment in patients with myelodysplastic syndrome” Turk J Haematol, 22, 117-123 (2005)
D4.Çetiner, M., I. Kaygusuz, T. Tecimer, E. Arı, E. Birtaş, F. Noyan, C. Adıgüzel, T. Fıratlı-Tuğlular, M. Bayık. “Myelodysplastic Syndrome with Pseudoreticulocytosis”, Tr J Haematol, 22, 41-44 (2005)
D5.Argon, D., M. Çetiner, C. Adıgüzel, I. Kaygusuz, T. Fıratlı-Tuğlular, T. Tecimer, M. Bayık. “Bone Marrow Necrosis in a Patient with Non-Hodgkin Lymphoma”, Turk J Haematol, 21, 97-100 (2004)
D6. Kartı SS, S. Ratip, M. Yılmaz, S. Ukınç, A. Örem, C. Adıgüzel, F. Dane, N. Kandemir, E. Ovalı, M. Bayık. “Therapeutic Trial of Cobalamin in Patients with Normal Serum Cobalamin Levels and Predicted Cobalamin Deficiency”. Turk J Haematol, 20, 69-74, (2003).
D7. Kartı, S., C. Adıgüzel, M. Yılmaz, M. Çetiner, S. Ratip, E. Ekşioğlu, S. Aktaş, N. Sofu, Y. Elbir, E. Ovalı, M. Bayık, “İki kriyoprezervasyon metodunun kök hücre canlılığı ve koloni oluşturma kapasitesi yönünden karşılaştırılması”, Türk Hematoloji Onkoloji Dergisi,4, 171-177 (2002).
D8. Kaya E, Albayrak A,Kendir T, Akdoğan F, İyikesici S, Uğur B, Masatlıoğlu S, Erten E, Adıgüzel C. Çeşitli nedenlere bağlı splenomegalilerde splenik ven çapı ile çevre kanındaki lökosit, granülosit, eritrosit ve trombosit değerlerinin ilişkileri. Haydarpaşa Numune Hastanesi Tıp Dergisi1996: 36(1): 37-43.
E. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler:
E1. Adıgüzel, C., M. Bayık, A-M. Maurer, A. Tolunay, E. Birtaş-Ateşoğlu, I. Kaygusuz, F. Atalay, M. Çetiner, T. Fıratlı-Tuğlular, H. Direskeneli, E. Ekşioğlu-Demiralp, “Trombozlu Behcet Hastalarında Matür Endotel, Aktif Endotel ve Endotel Progenitör Hücre Sayıları”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 10, Antalya, 2006
E2. Birtaş-Ateşoğlu, E., F. Atalay, A. Uzay, I. Kaygusuz, C. Adıgüzel, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Primer Tiroid Lenfoma – Olgu Sunumu”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 215, Antalya, 2006
E3. Adıgüzel, C., I. Kaygusuz, F. Atalay, E. Birtaş-Ateşoğlu, A. Uzay, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Allojeneik Kemik İliği Transplantasyonundan 13 yıl Sonra Relaps Yapan KML Hastasında İmatinib Mesilat Tedavisi”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 276, Antalya, 2006
E4. Kaygusuz, I., C. Adıgüzel, I. Köker, F. Atalay, E. Birtaş-Ateşoğlu, A. Uzay, T. Tecimer, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Glivec Tedavisi Almakta Olan Bir KML Hastasında Gelişen Kemik İliği Nekrozu”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 275, Antalya, 2006
E5. Kaygusuz, I., F. Yumuk, C. Adıgüzel, F. Atalay, E. Birtaş-Ateşoğlu, HB. Çağlar, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Glivec Tedavisi Almakta Olan Bir KML Hastasında Gelişen Meme Kanseri”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 274, Antalya, 2006
E6. Kaygusuz, I., M. Koç, C. Adıgüzel, E. Birtaş-Ateşoğlu, F. Atalay, A. Uzay, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “İdiopatik Miyelofibrosis Seyrinde Gelişen Fokal Segmental Glomeruloskleroz ”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 290, Antalya, 2006
E7. Atalay, F., E. Birtaş-Ateşoğlu, I. Kaygusuz, C. Adıgüzel, A. Uzay, T. Fıratlı-Tuğlular, M. Çetiner, M. Bayık. “Multipl Miyeloma Hastalarında Talidomid Toksisite Değerlendirmesi”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 301, Antalya, 2006
E8. Kaygusuz, I., C. Adıgüzel, F. Atalay, E. Birtaş-Ateşoğlu, A. Uzay, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık, “Multipl Miyeloma Hastalarında Bortezomib Toksisite Değerlendirmesi”, XXXII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 303, Antalya, 2006
E9. Noyan, F, C. Adıgüzel, T. Fıratlı-Tuğlular, I. Kaygusuz, E. Birtaş, M. Çetiner, M. Bayık. “KML’li Hastalarda Glivec Deneyimimiz”, XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 120, Antalya, 2004
E10. Çetiner, M., E. Birtaş, C. Adıgüzel, I. Kaygusuz, T. Fıratlı-Tuğlular, M. Bayık. “Marmara Bölgesi Hematoloji Kliniklerinde Transfüzyon Standartları ve Kalite Değerlendirilmesi”, XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı (sozel), 44-45, Antalya, 2004
E11. Çetiner, M., H. Beköz, C. Adıgüzel, F. Noyan, İ. Karadoğan, I. Kaygusuz, A. Timuroğlu, T. Fıratlı-Tuğlular, L. Ündar. “Akut Lenfoblastik Lösemi ve Lenfoblastik Lenfoma Tedavisinde Hiper-CVAD Kemoterapisinin Toksisite Profili (İki Merkez Deneyimi). XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 139, Antalya, 2004
E12. Birtaş, E., C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Polistemia Rubra ve Esansiyel Trombositemi Hastalarında Trombo-hemorajik Komplikasyonların Görülme Sıklığı. XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 148, Antalya, 2004
E13. Çetiner, M., I. Kaygusuz, E. Birtaş, C. Adıgüzel, F. Noyan, T. Tecimer, T. Fıratlı-Tuğlular, M. Bayık. “Myelodisplastik Sendrom ve Pseudoretikulositozis (Olgu Sunumu)”, XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 140, Antalya, 2004
E14. Kaygusuz, I., Z. Odabaşı, T. Fıratlı-Tuğlular, V. Korten, C. Adıgüzel, D. Argon, F. Noyan, M. Çetiner, M. Bayık. “Nötropenik bir Hastada İnvaziv Aspergillozis Seyrinde Kardiyak Tam Blok”, XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 186, Antalya, 2004
E15. Birtaş, E., T. Fıratlı-Tuğlular, I. Kaygusuz, F. Noyan, C. Adıgüzel, M. Çetiner, M. Bayık. “ALL Hastasında İntratekal Metotreksata bağlı Kauda Equina Sendromu. Vaka Sunumu”, XXXI. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 78, Antalya, 2004
E16. Adıgüzel, C., M. Sönmezoğlu, D. Argon, T. Akdeniz, E. Demiralp, M. Bayık. “Trombosit süspansiyonlarında ışınlanma, lökositten arındırma ve saklama sürelerinin trombosit aktivasyonu ve apoptoza etkilerinin “flow” sitometrik incelenmesi” . XXX. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, (sozel sunu), 74, İstanbul, 2003
E17. Argon, D., M. Çetiner, C. Adıgüzel, I. Kaygusuz, T. Fıratlı-Tuğlular, T. Tecimer, M. Bayık. “Olgu Sunumu: Diffüz B Hücreli Lenfomalı bir Hastada Yaygın Kemik İliği Nekrozu”. XXX. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 159, İstanbul, 2003
E18. Argon, D., M. Yüksel, C. Adıgüzel, M. Sönmezoğlu, , S. Yalçın, M. Bayık. “Aferez yoluyla elde edilmiş trombosit süspansiyonlarının, lökositten arındırılmaları, Işınlanmaları ve saklama sürelerinin serbest radikal oluşumu üzerine etkileri”. XXX. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, (sozel sunu), 74-75, İstanbul, 2003
E19. . Kaygusuz, I., M. Çetiner, S. Yapalı, C. Adıgüzel, D. Argon, P. Globi, Ş. Yavuz, T. Tecimer, T. Fıratlı, M. Bayık, “Common variable” İmmün Yetmezlik ve Lenfoma (iki olgu nedeniyle). XXX. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 132, İstanbul, 2003
E20. Birtaş, E., T. Fıratlı-Tuğlular, V. Korten, L. Mülazımoğlu, C. Adıgüzel, D. Argon, I. Kaygusuz, M. Çetiner, M. Bayık, “Hematolojik Malignansili Hastalarda Gelişen İnvaziv Fungal Enfeksiyonların Retrospektif Değerlendirilmesi”, XXX. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 160, İstanbul, 2003
E21. Kaygusuz, I., M. Çetiner, D. Morkoyun, D. Argon, C. Adıgüzel, T. Tecimer, T. Fıratlı-Tuğlular, M. Bayık, “CD 7 (+) Stem Cell Lenfoma: Olgu Sunumu”, XXX. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 132, İstanbul, 2003
E22. Argon, D., M. Çetiner, C. Adıgüzel, I. Kaygusuz, S. Ratip, M. Bayık, “Olgu sunumu: Kongenital Diseritropoetik Anemi Tip II (HEMPAS)”, XXIX.Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, Cilt IX, 184, Antalya, 2002.
E23. Adıgüzel, C., M. Çetiner, D. Argon, I. Kaygusuz, S. Ratip, T. Fıratlı Tuğlular, T. Tecimer, M. Bayık, “Spontan Dalak Rüptürü ile Prezante olan Splenik Marjinal Zon Lenfoma Zemininde Gelişmiş Büyük Hücreli Lenfoma”, XXIX.Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, Cilt IX, 184, Antalya, 2002.
E24. Argon, D., M. Çetiner, I. Kaygusuz, C. Adıgüzel, T. Fıratlı-Tuğlular, M. Bayık, “Olgu Sunumu: İzole Tiroid Bezi Tutulumu Gösteren Burkitt Lenfoma Olgusu (Evre IE)”, XXIX.Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, Cilt IX, 184, Antalya, 2002.
E25. Şeker, M., C. Gemici, Y. Koç, Ş. Güler, H. Sargın, M. Tekçe, T. Salepçi, C. Adıgüzel, A. Yayla, “Mide Ca seyrinde Gelişen bir Multiple Miyelom Olgusu” XXIX.Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, Cilt IX, 385, Antalya, 2002.
E26. Çetiner, M., AM. Maurer, P. Bizargity, D. Argon, C. Adıguzel, E. Eksioglu-Demiralp, M. Bayık, “Somatostaninin K567 hücre serisi ve KML’li kemik iliğinde hücre proliferasyonuna etkisi (ön çalışma)”. XXIX.Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, Cilt IX, 385, Antalya, 2002.
E27. Savcı, D., Ataizi, Ç. Çelikel, E. Kotiloğlu, H. Al Ahdab, C. Adıgüzel, M. Çetiner, T. Çelikel, “Bir Graft Versus Host Hastasında Obliteratif Bronşiolit: Olgu Sunumu”, XV. Ulusal Patoloji Kongresi, Bildiri Özet Kitabı, Adana, 2001.
E28. Adıgüzel, C., S. Ratip, E. Ekşioğlu, M. Çetiner, S. Kartı, S. Argon, T. Fıratlı-Tuğlular, M. Bayık, “Ailesel Timoma Saptanan Kızkardeşlerde “Pure Red Cell” Aplazi ve Myastenia Gravis”, XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 31, İzmir, 2000.
E29. Kartı, S., C. Adıgüzel, M. Çetiner, S. Ratip, E. Ekşioğlu, S. Aktaş, N. Sofu, Y. Elbir, E. Ovalı, M. Bayık, “Programlı ve Mekanik Dondurma Metodları ile Dondurularak Saklanan Kök Hücrelerin Canlılık ve Koloni Oluşturma Kapasitesi Yönünden Karşılaştırılması”, XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 184, İzmir, 2000.
E30. Kartı, S., C. Adıgüzel, M. Çetiner, S. Ratip, E. Ekşioğlu, S. Aktaş, N. Sofu, Y. Elbir, E. Ovalı, M. Bayık, “Kriyopreservasyon Öncesi Hücre Konsantrasyonunun Hücre Canlılığı ve Koloni Oluşturma Kapasitesi Üzerine Etkisi”, XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 187, İzmir, 2000.
E31. Ratip, S., C. Adıgüzel, E. Ekşioğlu, M. Çetiner, S. Kartı, D. Argon, T. Fıratlı-Tuğlular, M. Bayık, “Ailesel Hairy Cell Lösemi”, XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 32, İzmir, 2000.
E32. Çetiner, M., E. Ovalı, M.N. Yavuz, S. Ratip, S. Kartı, C. Adıgüzel, D. Argon, T. Fıratlı-Tuğlular, M. Bayık, “Radyasyonun Olumsuz Etkisinin Önlenmesinde Amifostine (WR-2721)’in Rolü (Ex Vivo Çalışma). XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 322, İzmir, 2000.
E33. Çetiner, M., E. Ovalı, M.N. Yavuz, S. Ratip, S. Kartı, C. Adıgüzel, D. Argon, T. Fıratlı-Tuğlular, M. Bayık, “Amifostine (WR-2721)’nin Normal Kemik İliği Üzerine Etkisi”, XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 323, İzmir, 2000.
E34. Çetiner, M., Y. Özen, M. Köse, S. Kartı, C. Adıgüzel, D. Argon, S. Ratip, T. Fıratlı-Tuğlular, E. Ovalı, M. Bayık, “Miyelodisplastik Sendromlu Olgularda Amifostine (WR-2721) Kullanımı”, XXVIII. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 30, İzmir, 2000.
E35. Adıgüzel, C., E. Kaya, N. Adıgüzel, N. Türkel, S. Çakır, A. Albayrak. “İskemik kalp hastalığında serum demir ve ferritin düzeyleri”. XV. Ulusal Kardiyoloji Kongresi, Bildiri Özet Kitabı, 293, İzmir, 1999.
E36. Çakır, S., S. Masatlıoğlu, S. Erten, C. Adıgüzel, H. Tepeli, F. Akdoğan, A. Albayrak. Çeşitli operasyonlarda post-operatif trombosit sayısı değişiklikleri. XXV. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 201, İstanbul, 1997.
E37. Kaya, E., F. Akdoğan, N. Türkel, C. Adıgüzel, A. Albayrak. İri granüllü lenfositik lösemili bir olgu sunumu. XXV. Ulusal Hematoloji Kongresi, Bildiri Özet Kitabı, 290, İstanbul, 1997.
Üyelikler
Türk Tabipleri Birliği (TTB)
Türk Hematoloji Derneği (THD)
Türk Tromboz , Hemostaz ve Anjioloji Derneği
American Society of Hematology (ASH)
International Society on Hemostasis and Thrombosis (ISTH)
Prof. Dr. Cafer Adıgüzel Medicana Sağlık Grubu'na ait MEDICANA ATAŞEHİR hastanesinde çalışmaktadır.
Prof. Dr. Cafer Adıgüzel hekimimizin HematolojiveKemik İliği Naklive alanında uzmanlığı bulunmaktadır.
